Black FridayUp to 80% OFF
Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg SPfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg SPfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S

Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S

No trades
See on Supercharts
OverviewFinancialsNewsIdeasMindsTechnicalsSeasonalsBonds

Chart


Full chart

Key facts today


The U.S. will announce negotiated prices for 15 costly drugs under Medicare, including Pfizer's Eliquis, likely cutting costs by 36% and saving about $8.5 billion.
Analyze the impactAnalyze the impact

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪202.39 B‬ CAD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
4.73
Basic EPS (TTM)
2.40 CAD
Net income (FY)
‪11.54 B‬ CAD
Revenue (FY)
‪91.56 B‬ CAD
Shares float
‪5.68 B‬
Beta (1Y)
0.57

About Pfizer, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Albert Bourla
Website
pfizer.com
Headquarters
New York
Founded
1849
ISIN
CA7170651060
FIGI
BBG013V20J83
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Check out other big names from the same industry as PFE.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


XS173899459
Pfizer Inc. 2.735% 15-JUN-2043
Yield to maturity
5.94%
Maturity date
Jun 15, 2043
P
PFE5588844
Pfizer Investment Enterprises Pte. Ltd. 5.34% 19-MAY-2063
Yield to maturity
5.69%
Maturity date
May 19, 2063
PFE6238667
Pfizer Inc. 5.7% 15-NOV-2065
Yield to maturity
5.65%
Maturity date
Nov 15, 2065
P
PFE5588843
Pfizer Investment Enterprises Pte. Ltd. 5.3% 19-MAY-2053
Yield to maturity
5.52%
Maturity date
May 19, 2053
PFE6238665
Pfizer Inc. 5.6% 15-NOV-2055
Yield to maturity
5.51%
Maturity date
Nov 15, 2055
US717081EK5
Pfizer Inc. 4.2% 15-SEP-2048
Yield to maturity
5.50%
Maturity date
Sep 15, 2048
US717081DE0
Pfizer Inc. 4.3% 15-JUN-2043
Yield to maturity
5.45%
Maturity date
Jun 15, 2043
US717081ED1
Pfizer Inc. 4.125% 15-DEC-2046
Yield to maturity
5.44%
Maturity date
Dec 15, 2046
US717081EV1
Pfizer Inc. 4.0% 15-MAR-2049
Yield to maturity
5.43%
Maturity date
Mar 15, 2049
US717081FA6
Pfizer Inc. 2.7% 28-MAY-2050
Yield to maturity
5.43%
Maturity date
May 28, 2050
US717081DK6
Pfizer Inc. 4.4% 15-MAY-2044
Yield to maturity
5.33%
Maturity date
May 15, 2044

See all PFE bonds 

Sparks


Curated watchlists where PFE is featured.

See all sparks